Growth differentiation factor 11: a rejuvenation factor involved in regulation of age-related diseases?

Growth differentiation factor 11 (GDF11), a member of the transforming growth factor beta superfamily of cytokines, is a critical rejuvenation factor in aging cells. GDF11 improves neurodegenerative and neurovascular disease outcomes, increases skeletal muscle volume, and enhances muscle strength. Its wide-ranging biological effects may include the reversal of senescence in clinical applications, as well as the ability to reverse age-related pathological changes and regulate organ regeneration after injury. Nevertheless, recent data have led to controversy regarding the functional roles of GDF11, because the underlying mechanisms were not clearly established in previous studies. In this review, we examine the literature regarding GDF11 in age-related diseases and discuss potential mechanisms underlying the effects of GDF11 in regulation of age-related diseases.

Automated summary

GDF11 is a critical rejuvenation factor that may improve outcomes in neurodegenerative and neurovascular diseases, as well as muscle health. There is controversy regarding its functional roles, but it shows potential for reversing age-related pathological changes and regulating organ regeneration.